Chronic Disease, Dementia, Diabetes With End Organ Injury, Heart Failure,Congestive, Kidney Failure, Chronic, Liver Cirrhosis, Lung Diseases, Interstitial, Lung Neoplasm, Neoplasm Metastasis, Peripheral Vascular Disease, Pulmonary Disease, Chronic Obstructive
Conditions
Keywords
Health care quality, access, and evaluation, Patient care, Inpatients, Health communication, Patient care planning, Palliative care
Brief summary
The objective of this protocol is to test the effectiveness of a Jumpstart intervention on patient-centered outcomes for patients with chronic illness by ensuring that they receive care that is concordant with their goals over time, and across settings and providers. This study will examine the effect of the EHR-based intervention to improve quality of palliative care for patients 55 years or older with chronic, life-limiting illness with a particular emphasis on Alzheimer's disease and related dementias (ADRD). The specific aims are: 1. To evaluate the effectiveness of a novel EHR-based (electronic health record) clinician Jumpstart guide, compared with usual care, for improving the quality of care; the primary outcome is documentation of a goals-of-care discussion in the period between randomization and 30 days following randomization. Secondary outcomes focus on intensity of care: ICU use, ICU and hospital length of stay, costs of care during the hospitalization, and 7 and 30-day hospital readmissions. 2. To conduct a mixed-methods evaluation of the implementation of the intervention, guided by the RE-AIM framework for implementation science, incorporating quantitative evaluation of the intervention's reach and adoption, as well as qualitative analyses of interviews with participants, to explore barriers and facilitators to future implementation and dissemination.
Detailed description
OVERVIEW: This is a large pragmatic trial of the Jumpstart intervention designed to promote goals-of-care discussions for older, seriously ill, hospitalized patients. The trial recruits consecutively eligible patients from three UW Medicine hospitals. The Jumpstart Guide is a communication-priming intervention that addresses hospitalized patients' goals of care. It includes information, drawn from the electronic health record (EHR), identifying the dates and locations of prior advance care planning documents (e.g. living wills, healthcare directives, durable power of attorney for healthcare, and Physician Orders for Life Sustaining Treatments (POLST)) and patients' code status. This information is provided by email to patients' clinicians. The Jumpstart Guide includes tips to improve this communication. The trial will assess the effectiveness of the EHR-based clinician Jumpstart as compared with usual care. This current study is Trial 1 of the R01 Award funding this trial. Trial 2 was initiated following the completion of recruitment for Trial 1. SPECIFIC AIM 1 (for Trial 1): Evaluate the efficacy of the EHR-based clinician Jumpstart compared to usual care for improving quality of care. TRIAL 1 has three components. Component 1- Subject Identification/Recruitment/Randomization: The investigators will use automated methods with EHR data, including natural language processing/machine learning (NLP/ML) approaches, to identify hospitalized patients with serious illness during the first 2-3 days of this specific admission. Screening reports will be produced daily and include all likely eligible patients. Study staff will use these daily screening reports to review individual records of eligible patients for inclusion and exclusion criteria (i.e. verify eligibility). Patients will not be approached for consent. Eligible patients will be assigned to intervention or comparator in a 1:1 ratio. Patients are randomized using variable size blocks and stratified for hospital and ADRD vs. no ADRD. Component 2- EHR-based Clinician Jumpstart Guide: The Jumpstart guide is developed by applying NLP/ML algorithms to both inpatient and outpatient EHR notes (e.g., progress notes, specialty consult notes, alerts and care plans) preceding the current hospitalization. It summarizes the presence/absence of POLST, advance directives and DPOA (durable power of attorney) documentation and the patients' code status. It also provides general recommendations to initiating goals of care discussions. Jumpstart guides are prepared for the intervention group only. Component 3- Delivery of the intervention: For the intervention group, the investigators deliver the Jumpstart guide to the primary hospital team (attending and resident physicians and advanced practice providers) via secure email. The Jumpstart guides are delivered within 1 business day of patient randomization. Study staff monitor the care team of the patient, and if there are any changes, ensure that any new providers receive the Jumpstart guide as well. Comparator: The hospital teams for patients in the control group do not receive Jumpstart guides. Outcome Assessment. Outcomes are obtained from the EHR and use, in part, NLP/ML methods. The primary outcome is EHR documentation of goals-of-care discussions in the 30 days following randomization. Secondary outcomes are measures of intensity of care, including utilization metrics (i.e., ICU admissions, ICU and hospital lengths of stay, 30-day hospital readmissions), costs of care during hospital admission, and estimated costs of implementing the intervention. SPECIFIC AIM 2 (Trial 1): Evaluate implementation of the Jumpstart Guide and identify barriers and facilitators to future implementation. Qualitative evaluation: Clinician recruitment: Study staff will recruit clinicians who were involved with the study to participate in a short interview after the clinician's study involvement with the enrolled patient has ended. Clinician participants will be selected using purposive sampling to ensure a diverse group (e.g., age, race/ethnicity, gender, specialty, year of training). Interview: Using an interview guide developed specifically for this project, interviewers will assess respondents' experience with the intervention and gather suggestions for ways to improve the intervention's content, delivery and implementation, including implementation outcomes (e.g., acceptability, fidelity, penetration, maintenance) that will guide future dissemination of the intervention. Assessment: Interviews are audio recorded, transcribed, and analyzed using thematic analytic methods. Quantitative evaluation: Quantitative evaluation for Specific Aim 2 will be guided by the RE-AIM framework. We will evaluate the intervention's: 1) Reach (% of all identified eligible clinicians, patients and families that participated in the study); 2) Adoption (% of eligible services that participated); and 3) Implementation (the proportion of HTML Jumpstart Guides that were opened by a clinician, proportion of patients for whom an HTML JS guide was sent and for whom a JS was opened by a clinician).
Interventions
The Jumpstart Guide is a communication-priming intervention for clinicians that addresses hospitalized patients' goals of care. The intervention's goal is to prompt clinicians to provide standard of care which includes a discussion with patients or their legal surrogate decision-maker about their goals of care. The one-page Jumpstart Guide provides information to the clinician about prior advance care planning documentation and code status derived from the EHR. The Jumpstart Guides includes tips to improve goals-of-care communication.
Sponsors
Study design
Eligibility
Inclusion criteria
Eligibility criteria apply to two subject groups: 1) seriously ill adult patients; 2) hospital clinicians. Inclusion Criteria: * PATIENTS. Eligible patients will be those who are: 1) older than 80 years of age; or 2) 55 years of age or older who meet criteria for serious illness. Serious illness encompasses acute illness (e.g. COVID-19) and chronic illnesses (e.g. those included in the Dartmouth Atlas to study end-of-life care: malignant cancer/leukemia, chronic pulmonary disease, coronary artery disease, heart failure, chronic liver disease, chronic renal disease, dementia, diabetes with end-organ damage, and peripheral vascular disease). * CLINICIANS (Interview). Eligible clinicians will be those who are 18 years of age or older, English-speaking, employed at a participating hospital, and have been the clinician of record for an enrolled patient in the trial.
Exclusion criteria
* Reasons for exclusion for any patient include: restricted status (prisoners or victims of violence); legal or risk management concerns (as determined by the attending physician or via hospital record designation).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of Patients With EHR Documentation of Goals of Care Discussions | Assessed for the period between randomization and 30 days following randomization | The primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intensity of Care: ICU Admissions 30 Days | Assessed for the period between randomization and 30 days following randomization | Secondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients who received ICU care. |
| Intensity of Care/ICU Use: ICU Admissions | Assessed for the period between randomization and 30 days following randomization | Secondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU admissions during the patient's (index) hospital stay will be collected from the EHR. |
| Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU) | Assessed for the period between randomization and 30 days following randomization | Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the ICU within 30 days from randomization will be collected from the EHR. |
| Intensity of Care: Hospital Readmissions 30 Days | Assessed for the period between randomization and 30 days following randomization | Secondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients readmitted to the hospital following index hospitalization. |
| Total Hospitalization Costs, Randomization to 30 Days After Randomization | Assessed for the period between randomization and 30 days later | Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation. |
| All-cause Mortality at 30 Days After Randomization (Safety Outcome) | 30 days after randomization | From Washington State death certificates |
| Total Hospitalization Costs, Randomization to Index Hospitalization Discharge | Index hospital stay | Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation. Assessed for the period between randomization and discharge for the index hospital stay. |
| Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital) | Assessed for the period between randomization and 30 days following randomization | Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the hospital within 30 days from randomization will be collected from the EHR. |
Countries
United States
Participant flow
Recruitment details
PATIENTS recruited from 4/23/20 to 3/26/21. A waiver of informed consent and HIPAA authorization obtained for screening and enrollment.
Pre-assignment details
4567 potentially eligible patients identified; 4395 patients screened (1883 ineligible, 2512 eligible); 2512 enrolled.
Participants by arm
| Arm | Count |
|---|---|
| EHR-based Clinician Jumpstart The EHR-based Jumpstart Guide will be developed by extracting data from the EHR to identify documents uploaded prior to the current hospitalization. It will summarize the presence/absence of POLST, advance directives and DPOA documentation and patients' code status.
EHR-based Clinician Jumpstart: The Jumpstart Guide is a communication-priming intervention for clinicians that addresses hospitalized patients' goals of care. The intervention's goal is to prompt clinicians to provide standard of care which includes a discussion with patients or their legal surrogate decision-maker about their goals of care. The one-page Jumpstart Guide provides information to the clinician about prior advance care planning documentation and code status derived from the EHR. The Jumpstart Guides includes tips to improve goals-of-care communication. | 1,255 |
| Usual Care The clinicians (hospital teams) for patients in the control group will not receive Jumpstart guides. These subjects will receive usual care. | 1,257 |
| Total | 2,512 |
Baseline characteristics
| Characteristic | EHR-based Clinician Jumpstart | Usual Care | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 878 Participants | 845 Participants | 1723 Participants |
| Age, Categorical Between 18 and 65 years | 377 Participants | 412 Participants | 789 Participants |
| Age, Continuous | 71.8 years STANDARD_DEVIATION 10.7 | 71.6 years STANDARD_DEVIATION 10.9 | 71.7 years STANDARD_DEVIATION 10.8 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 77 Participants | 73 Participants | 150 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 1171 Participants | 1176 Participants | 2347 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 7 Participants | 8 Participants | 15 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 21 Participants | 24 Participants | 45 Participants |
| Race (NIH/OMB) Asian | 143 Participants | 149 Participants | 292 Participants |
| Race (NIH/OMB) Black or African American | 168 Participants | 148 Participants | 316 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 4 Participants | 9 Participants | 13 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 37 Participants | 41 Participants | 78 Participants |
| Race (NIH/OMB) White | 882 Participants | 886 Participants | 1768 Participants |
| Region of Enrollment United States | 1255 participants | 1257 participants | 2512 participants |
| Sex: Female, Male Female | 543 Participants | 513 Participants | 1056 Participants |
| Sex: Female, Male Male | 712 Participants | 744 Participants | 1456 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 70 / 1,255 | 64 / 1,257 |
| other Total, other adverse events | 0 / 1,255 | 0 / 1,257 |
| serious Total, serious adverse events | 0 / 1,255 | 0 / 1,257 |
Outcome results
Proportion of Patients With EHR Documentation of Goals of Care Discussions
The primary outcome is the proportion of patients who have a goals-of-care (GOC) discussion that has been documented in the EHR in the period between randomization and 30 days following randomization The proportion is the number of patients with GOC documentation over the number of patients in each study arm. Documentation of goals-of-care discussions will be evaluated using our NLP/ML methods.
Time frame: Assessed for the period between randomization and 30 days following randomization
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| EHR-based Clinician Jumpstart | Proportion of Patients With EHR Documentation of Goals of Care Discussions | GOC documented | 433 Participants |
| EHR-based Clinician Jumpstart | Proportion of Patients With EHR Documentation of Goals of Care Discussions | GOC not documented | 822 Participants |
| Usual Care | Proportion of Patients With EHR Documentation of Goals of Care Discussions | GOC documented | 382 Participants |
| Usual Care | Proportion of Patients With EHR Documentation of Goals of Care Discussions | GOC not documented | 875 Participants |
All-cause Mortality at 30 Days After Randomization (Safety Outcome)
From Washington State death certificates
Time frame: 30 days after randomization
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| EHR-based Clinician Jumpstart | All-cause Mortality at 30 Days After Randomization (Safety Outcome) | Deceased at 30 days | 64 Participants |
| EHR-based Clinician Jumpstart | All-cause Mortality at 30 Days After Randomization (Safety Outcome) | Alive at 30 days | 1193 Participants |
| Usual Care | All-cause Mortality at 30 Days After Randomization (Safety Outcome) | Alive at 30 days | 1185 Participants |
| Usual Care | All-cause Mortality at 30 Days After Randomization (Safety Outcome) | Deceased at 30 days | 70 Participants |
Intensity of Care: Hospital Readmissions 30 Days
Secondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients readmitted to the hospital following index hospitalization.
Time frame: Assessed for the period between randomization and 30 days following randomization
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| EHR-based Clinician Jumpstart | Intensity of Care: Hospital Readmissions 30 Days | 265 Participants |
| Usual Care | Intensity of Care: Hospital Readmissions 30 Days | 251 Participants |
Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital)
Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the hospital within 30 days from randomization will be collected from the EHR.
Time frame: Assessed for the period between randomization and 30 days following randomization
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| EHR-based Clinician Jumpstart | Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital) | 21.99 days | Standard Deviation 8.78 |
| Usual Care | Intensity of Care/Hospital Use: Hospital Length of Stay (Number of Days Alive and Out of the Hospital) | 21.63 days | Standard Deviation 9.15 |
Intensity of Care: ICU Admissions 30 Days
Secondary outcomes include measures of intensity of care, including utilization metrics: Proportion of patients who received ICU care.
Time frame: Assessed for the period between randomization and 30 days following randomization
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| EHR-based Clinician Jumpstart | Intensity of Care: ICU Admissions 30 Days | 336 Participants |
| Usual Care | Intensity of Care: ICU Admissions 30 Days | 348 Participants |
Intensity of Care/ICU Use: ICU Admissions
Secondary outcomes include measures of intensity of care, including utilization metrics: Number of ICU admissions during the patient's (index) hospital stay will be collected from the EHR.
Time frame: Assessed for the period between randomization and 30 days following randomization
Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU)
Secondary outcomes include measures of intensity of care, including utilization metrics: Number of days alive and out of the ICU within 30 days from randomization will be collected from the EHR.
Time frame: Assessed for the period between randomization and 30 days following randomization
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| EHR-based Clinician Jumpstart | Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU) | 27.90 days | Standard Deviation 6.12 |
| Usual Care | Intensity of Care/ICU Use: ICU Length of Stay (Number of Days Alive and Out of the ICU) | 27.83 days | Standard Deviation 6.19 |
Total Hospitalization Costs, Randomization to 30 Days After Randomization
Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation.
Time frame: Assessed for the period between randomization and 30 days later
Population: (Data unavailable from Finance Office for two patients.)
| Arm | Measure | Value (MEAN) |
|---|---|---|
| EHR-based Clinician Jumpstart | Total Hospitalization Costs, Randomization to 30 Days After Randomization | 21,908.67 US dollars |
| Usual Care | Total Hospitalization Costs, Randomization to 30 Days After Randomization | 22,386.40 US dollars |
Total Hospitalization Costs, Randomization to Index Hospitalization Discharge
Secondary outcomes include measures of intensity of care, including costs of inpatient care, collected from UW Medicine Finance Office and adjusted for inflation. Assessed for the period between randomization and discharge for the index hospital stay.
Time frame: Index hospital stay
Population: (Data unavailable from Finance Office for two patients.)
| Arm | Measure | Value (MEAN) |
|---|---|---|
| EHR-based Clinician Jumpstart | Total Hospitalization Costs, Randomization to Index Hospitalization Discharge | 24,384.68 US dollars |
| Usual Care | Total Hospitalization Costs, Randomization to Index Hospitalization Discharge | 23,724.06 US dollars |